These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 15745795)

  • 41. Binding-site identification and genotypic profiling of hepatitis C virus polymerase inhibitors.
    Pauwels F; Mostmans W; Quirynen LM; van der Helm L; Boutton CW; Rueff AS; Cleiren E; Raboisson P; Surleraux D; Nyanguile O; Simmen KA
    J Virol; 2007 Jul; 81(13):6909-19. PubMed ID: 17459932
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Optimization of novel acyl pyrrolidine inhibitors of hepatitis C virus RNA-dependent RNA polymerase leading to a development candidate.
    Slater MJ; Amphlett EM; Andrews DM; Bravi G; Burton G; Cheasty AG; Corfield JA; Ellis MR; Fenwick RH; Fernandes S; Guidetti R; Haigh D; Hartley CD; Howes PD; Jackson DL; Jarvest RL; Lovegrove VL; Medhurst KJ; Parry NR; Price H; Shah P; Singh OM; Stocker R; Thommes P; Wilkinson C; Wonacott A
    J Med Chem; 2007 Mar; 50(5):897-900. PubMed ID: 17269759
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A highly efficient, asymmetric synthesis of benzothiadiazine-substituted tetramic acids: potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Fitch DM; Evans KA; Chai D; Duffy KJ
    Org Lett; 2005 Nov; 7(24):5521-4. PubMed ID: 16288546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of novel HCV RNA-dependent RNA polymerase inhibitors using pharmacophore-guided virtual screening.
    Kim J; Kim KS; Kim DE; Chong Y
    Chem Biol Drug Des; 2008 Dec; 72(6):585-91. PubMed ID: 19090925
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, potent inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Tedesco R; Shaw AN; Bambal R; Chai D; Concha NO; Darcy MG; Dhanak D; Fitch DM; Gates A; Gerhardt WG; Halegoua DL; Han C; Hofmann GA; Johnston VK; Kaura AC; Liu N; Keenan RM; Lin-Goerke J; Sarisky RT; Wiggall KJ; Zimmerman MN; Duffy KJ
    J Med Chem; 2006 Feb; 49(3):971-83. PubMed ID: 16451063
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An efficient, asymmetric solid-phase synthesis of benzothiadiazine-substituted tetramic acids: potent inhibitors of the hepatitis C virus RNA-dependent RNA polymerase.
    Evans KA; Chai D; Graybill TL; Burton G; Sarisky RT; Lin-Goerke J; Johnston VK; Rivero RA
    Bioorg Med Chem Lett; 2006 Apr; 16(8):2205-8. PubMed ID: 16455253
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of small molecule inhibitors of the hepatitis C virus RNA-dependent RNA polymerase from a pyrrolidine combinatorial mixture.
    Burton G; Ku TW; Carr TJ; Kiesow T; Sarisky RT; Lin-Goerke J; Baker A; Earnshaw DL; Hofmann GA; Keenan RM; Dhanak D
    Bioorg Med Chem Lett; 2005 Mar; 15(6):1553-6. PubMed ID: 15745795
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Selective inhibitors of hepatitis C virus replication.
    Neyts J
    Antiviral Res; 2006 Sep; 71(2-3):363-71. PubMed ID: 16843538
    [TBL] [Abstract][Full Text] [Related]  

  • 49.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 50.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 51.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 52.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 53.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 54.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 55.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 3.